Currently, it is believed that the Epstein-Barr virus (EBV) infection and inflammatory cytokines (such as TNF-α) are strong stimuli of NF-κB activation in NPC patients [17, 18]. This evidence concerns the gene TNF and nasopharyngeal carcinoma.